Stratec (ETR:SBS) Stock Price Down 1.4% – Time to Sell?

Stratec SE (ETR:SBSGet Free Report)’s share price fell 1.4% during mid-day trading on Friday . The company traded as low as €21.70 and last traded at €21.70. 16,852 shares traded hands during mid-day trading, an increase of 170% from the average session volume of 6,253 shares. The stock had previously closed at €22.00.

Stratec Price Performance

The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65. The firm has a market capitalization of $263.70 million, a P/E ratio of 26.34, a PEG ratio of 10.43 and a beta of 0.16. The company’s 50 day moving average price is €24.30 and its 200 day moving average price is €26.07.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Read More

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.